美国深 inferior 腹壁动脉穿支皮瓣乳房重建的成本-容量分析
基于2016-2019年全国再入院数据库,评估医院年手术量与深 inferior 腹壁动脉穿支皮瓣乳房重建成本的关系。高容量医院的中位成本更低,调整后住院成本减少3800美元,且围术期并发症 odds 降低,但住院时间和30天非计划再入院无差异。
要点
- 调整后高容量状态与住院成本减少3800美元相关(95%CI:-6200至-1400)。
- 高容量状态与围术期并发症 odds 降低相关(aOR 0.68,95%CI 0.54-0.86)。
核心结论
- DIEP皮瓣乳房重建存在成本-容量负相关,高容量医院成本更低且并发症更少。
研究设计与样本
- 回顾性队列研究,使用2016-2019年全国再入院数据库,纳入94524例女性乳房重建患者,其中33046例(34.6%)接受DIEP皮瓣重建。
主要发现
- 调整后高容量状态与住院成本减少3800美元相关(95%CI -6200至-1400),并降低围术期并发症 odds(aOR 0.68,95%CI 0.54-0.86)。
- 高容量状态与住院时间或30天非计划再入院可能性无关。
临床怎么用
- 研究结果可提示DIEP皮瓣乳房重建的转诊模式,倾向于选择高容量中心以符合价值医疗目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep inferior epigastric artery perforator flaps are increasingly utilized over other autologous methods of breast reconstruction. We evaluated the relationship between annual hospital volume and costs after breast reconstruction with the deep inferior epigastric artery perforator flap. METHODS: All female patients undergoing elective implant or autologous tissue breast reconstruction were identified using the 2016-2019 Nationwide Readmission Database. Annual hospital volume of deep inferior epigastric artery perforator reconstructions was tabulated and modeled using restricted cubic splines. Institutions were categorized into high- and low-volume based on the inflection point of the spline between annual caseload and costs. The association between high volume status and costs, complications, length of stay, and 30-day nonelective readmission was assessed using multivariable regression. RESULTS: Of an estimated 94,524 patients meeting inclusion criteria, 33,046 (34.6%) underwent deep inferior epigastric artery perforator flap reconstruction. Deep inferior epigastric artery perforator flap utilization increased from 31% in 2016 to 40% in 2019 (P < .001) among inpatient breast reconstructions. High-volume hospitals more frequently performed bilateral reconstructions (43.3 vs 37.7%, P = .021) but had similar rates of concurrent mastectomy (28.7 vs 30.6%, P = .46), relative to low-volume hospitals. The median cost of deep inferior epigastric artery perforator reconstruction was lower ($29,900 [interquartile range: 22,400-37,400] vs $31,600 [interquartile range: 22,500-44,900], P = .036) at high-volume hospitals compared to low-volume. On adjusted analysis, high-volume status was associated a $3,800 (95% confidence interval: -6,200 to -1,400) decrement in hospitalization costs, and reduced odds of perioperative complications (adjusted odd ratio: 0.68 95% confidence interval: 0.54-0.86). High-volume status was not associated with length of stay or likelihood of unplanned readmission. CONCLUSION: The present study demonstrated an inverse cost-volume relationship in deep inferior epigastric artery perforator flap breast reconstruction. In line with goals of value-based health care delivery, our findings may inform referral patterns to suitable centers for deep inferior epigastric artery perforator breast reconstruction.
引用
- Park M, Verma A, Madrigal J, et al. Cost-volume analysis of deep inferior epigastric artery perforator flaps for breast reconstruction in the United States. Surgery. 2022. PMID: 35710535. doi:10.1016/j.surg.2022.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。